论文部分内容阅读
目的：旨在了解巨大肝癌采用不同治疗方法的疗效。材料与方法：回顾性调查９２例巨大肝癌的临床及随访资料，根据不同治疗方法分成手术切除、姑息性治疗和ＴＡＥ三组，统计治疗后的疗效。采用寿命表法对三组的生存率作比较分析。结果：１、２、３年生存率，手术切除组分别为６０％、４２．８６％和３３．３４％；ＴＡＥ组分别为５３．６２％、２８．６０％和４．７７％；姑息性治疗组分别为２５．２８％、８．４３％和０％。结论：手术切除疗效优于ＴＡＥ和姑息性治疗。
Purpose: To understand the efficacy of different treatment methods for large HCC. Materials and Methods: The clinical and follow-up data of 92 cases of hepatocellular carcinoma were retrospectively reviewed. According to different treatment methods, surgical resection, palliative treatment and TAE were divided into three groups, and the curative effect was evaluated statistically. The life table method was used to compare the survival rates of the three groups. Results: The 1-, 2-, and 3-year survival rates were 60%, 42.86%, and 33.34% in the surgical resection group, 53.62%, 28.60%, and 4.77% in the TAE group, respectively; palliative The treatment group was 25.28%, 8.43%, and 0%, respectively. Conclusion: The surgical resection is superior to TAE and palliative treatment.